Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Polycythemia: from clones to clinic

|November 1, 1993

Summary

Reclassifying polycythemia is crucial due to new diagnostic criteria for pathological erythroid clones. Advanced molecular biology aids in distinguishing polycythemia vera from other red cell disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rearrangement of T-cell Receptor (Delta, Gamma and Beta) Genes and its Significance in T-cell Chronic Leukaemias.

Leukemia & lymphoma·2016

Same author

Molecular biology of Philadelphia chromosome in chronic granulocytic leukaemia and acute lymphoblastic leukaemia.

Cytotechnology·2012

Same author

Mammalian artificial chromosomes: A review.

Cytotechnology·2012

Same author

Biological inducers of haemopoietic differentiation.

Cytotechnology·2012

Same author

Cultures of haemopoietic cells: principles and applications.

Cytotechnology·2012

Same author

Versatile stem cells, young and old. A review.

Cytotechnology·2008

Area of Science:

Hematology
Molecular Biology
Genetics

Background:

Growing evidence of pathological erythroid clones necessitates re-evaluating polycythemia classification.
Distinguishing primary proliferative polycythemia (polycythemia vera) from other causes of erythrocytosis is critical.

Discussion:

Review of abnormal erythropoietic clone characteristics in polycythemia vera, including Epo-independent growth.
Integration of traditional criteria with newer parameters and clinical features for accurate diagnosis.
Examination of idiopathic erythrocytosis and other polycythemia forms (familial, secondary, apparent).

Key Insights:

Molecular biology advancements are elucidating previously obscure polycythemia forms by identifying genetic defects.
Understanding erythropoietic initiators like Epo receptor and GATA-1 is key to comprehending clinical polycythemia.

Outlook:

New insights are improving the diagnosis and treatment strategies for various polycythemia types.
Continued research in molecular mechanisms promises further refinement in clinical management.

Related Experiment Videos